On January 19th and 20, the Chinese clinical neuroscience Summit (CNS) and the ceremony to license the second batch of members of the Tiantan Neurologic Disease Alliance (hereinafter referred to as the “the alliance”) were held in the new Huaxiang campus. Zhang Zongjiu, who is director of the health and Family Planning Committee of the state health, Lei Haichao, who is director of the health and Family Planning Committee of Beijing, Pan Suyan, who is deputy director of the Beijing hospital administration attended this meeting. As representatives from membership units, Zhao Jizong, director of China National Clinical Research Center for Neurological Diseases, Wang Yongjun, executive vice president of our hospital, and Lu Ming, the secretary of the party committee, gave licenses to the second batch of membership hospitals. The alliance has attracted nearly 300 members of three grade hospitals with the advantage of neuroscience, covering 31 provinces, municipalities and autonomous regions except Hong Kong, Macao and Taiwan. In the future, the alliance will be committed to the integration of medical resources, through the establishment of a unified technical standard, clinical path, diagnosis and treatment norms and service management standards, to facilitate the majority of patients in the country to enjoy the "Tiantan standard" medical service at home.